Willow Biosciences (TSX:WLLW) Accounts Payable & Accrued Expense : C$0.70 Mil (As of Sep. 2024)

View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Accounts Payable & Accrued Expense?

Willow Biosciences's quarterly accounts payable & accrued expense increased from Mar. 2024 (C$0.48 Mil) to Jun. 2024 (C$1.19 Mil) but then declined from Jun. 2024 (C$1.19 Mil) to Sep. 2024 (C$0.70 Mil).

Willow Biosciences's annual accounts payable & accrued expense increased from Dec. 2021 (C$0.76 Mil) to Dec. 2022 (C$1.09 Mil) but then declined from Dec. 2022 (C$1.09 Mil) to Dec. 2023 (C$0.64 Mil).

Willow Biosciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Willow Biosciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Accounts Payable & Accrued Expense Chart

Willow Biosciences Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.10

0.98

0.76

1.09

0.64

Willow Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.84	0.64	0.48	1.19	0.70

Willow Biosciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CANSF:USA

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Executives

Christopher Kenneth Savile	Director, Senior Officer
Travis Doupe	Senior Officer
Patricia Ranija Choudhary	Director
Sadiq Lalani	Director
Barbara Elaine Munroe	Director
Peter Seufer-wasserthal	Director
Trevor Anthony Peters	Director, Senior Officer
Troy Tapan Talkkari	Senior Officer

Willow Biosciences Headlines

No Headlines